Jan. 27, 2024

Ronan O’Hagan - President & CEO, Bectas Therapeutics Inc.

Ronan O’Hagan, President & CEO, Bectas Therapeutics Inc.  Rónán is a founder and the President and Chief Executive Officer for Bectas Therapeutics Inc. He has over 20 years of experience in oncology R&D including bringing over 20...

Ronan O’Hagan, President & CEO, Bectas Therapeutics Inc.  Rónán is a founder and the President and Chief Executive Officer for Bectas Therapeutics Inc. He has over 20 years of experience in oncology R&D including bringing over 20 molecules through IND and into clinical development and helping to guide 4 drugs through clinical development to FDA approval.

 

  • Ronan O'Hagan is the President and CEO of Bectas Therapeutics, a cancer drug discovery and development company with over 20 years of experience in oncology R&D. He has been instrumental in advancing over 20 molecules through IND (Investigational New Drug) to clinical development and guiding four drugs through clinical trials to FDA approval.
  • His approach at Bectas Therapeutics focuses on utilizing insights from human patients' immune responses to develop precision therapies, aiming to find the right drug for the right patient. This approach stems from his belief that understanding cancer's complexity requires a deep understanding of patients themselves.
  • O'Hagan's career includes significant roles in various organizations: Chief Scientific Officer at Apricity Health and Exilio Therapeutics, leader of the Oncology Discovery team at Merck Research Labs, and involvement in a biotech startup originating from Dana Farber Cancer Institute.
  • He emphasizes the importance of values like focusing on patients, people, and proof of concept in drug development. He believes in balancing innovation with discipline and highlights the need for collaborative but strong leadership in the pharmaceutical industry.
  • O'Hagan discusses the challenges and triumphs of drug development, stressing the importance of speed in bringing therapies to patients and the need for alignment around core values within a team. He also underlines the role of precision in enhancing the effectiveness of immune therapies and the necessity of inclusive research to benefit diverse patient populations.

Please check out our Life Science Success Resources.  You will find tools that will support growing companies and books for authors I have interviewed.  

New to the podcast?

Aug. 11, 2023

Thomas Farb-Horch - CEO of Thrive Bio

This week on the Life Science Success podcast, my guest is Thomas Farb-Horch. Thomas is the CEO of Thrive Bio. He has been involved in the founding of 18 pharmaceutical, biotech, medtech, software, and AI companies, 7 of which have …

Listen to the Episode
Nov. 18, 2023

Cristian Massacesi - Chief Medical Officer & Oncology Chief Developme…

In this episode of Life Science Success, my guest is Cristian Massacesi MD. Cristian is the Chief Medical Officer & Oncology Chief Development Officer at AstraZeneca. In the interview, we will discuss his start in oncology, his career...

Listen to the Episode
March 17, 2024

The Power of GenAI in Life Sciences - Elizabeth Smalley ArisGlobal

This week on Life Science Success, we are thrilled to welcome back Elizabeth Smalley as our guest. Elizabeth is the VP, Product Management, Data & Analytics at ArisGlobal, where she plays a pivotal role in steering the company’s strategic...

Listen to the Episode
April 6, 2024

Dr. Mohit Jain Unveils Next-Gen Tech in Drug Discovery & Therapy

In this episode of Life Science Success, host Don Davis has a conversation with Dr. Mohit Jain, a physician scientist with extensive experience in physiology, biomedicine, and mass spectrometry. Dr. Jain shares his unique journey from clinical...

Listen to the Episode
May 25, 2024

Christiaan Engstrom CEO Bullpen & Bio 2024 Events

In this episode of the Life Science Success Podcast, host Don Davis interviews Christian Engstrom, CEO of Bullpen, an elite club focused on fostering collaborative success in the life sciences industry. They discuss Christian's background, his...

Listen to the Episode
June 29, 2024

Unlocking Precision Cancer Care with Tushar Pandey CEO Symbiosys

Tushar Pandey is a distinguished expert in the Life Sciences industry, currently making significant strides at SimBioSys with his innovative approach to healthcare technology. His contributions have been pivotal in advancing medical solutions and...

Listen to the Episode
June 29, 2024

How William Hind's Belief Continuum is Revolutionizing Pharma Communi…

In this episode of Life Science Success, my guest is William Hind. William, the founder of Alpharmaxim, is transforming how pharma companies communicate their value to healthcare providers. In this episode of Life Science Success, host Don interviews...

Listen to the Episode